Le Lézard
Classified in: Health
Subject: MAT

Choom Announces Expansion in Ontario


VANCOUVER, March 3, 2020 /CNW/ - Choomtm (CSE: CHOO; OTCQB: CHOOF), an emerging adult use cannabis company that has secured one of the largest national retail networks in Canada, is pleased to announce that it has submitted applications to the Alcohol and Gaming Commission of Ontario ("AGCO") for Retail Store Authorizations for a further four locations in Ontario.

Ontario Locations

Toronto (Liberty Village)

#3, 61 Hanna Avenue

Ottawa (Trainyards)

#10, 500 Terminal Avenue

Kitchener (Sunrise)

#B-8, 1400 Ottawa Street S.

Hamilton (Southeast)

#E001, 2190 Rymal Road E.

Ontario is a key strategic growth center for Choom Holdings Inc., says Corey Gillon, CEO, "The exceptional quality of our Ontario locations demonstrates both a commitment to Ontario and the capabilities of our team to secure premium brick and mortar locations".

Updates on openings, approvals and operating hours of these new stores are located on Choom's website at https://choom.ca/retail#Ontario

For more information, visit choom.ca.

Say hello to Choomtm
Choomtm is an emerging adult use cannabis company whose mission is to establish one of the largest retail networks in Canada. The Choom brand is inspired by Hawaii's "Choom Gang"?a group of buddies in Honolulu during the 1970's who loved to smoke weed?or as the locals called it, "Choom". Evoking the spirit of the original Choom Gang, our brand caters to the Canadian adult use market with the ethos of 'cultivating good times'. Choomtm is focused on delivering an elevated customer experience through our curated retail environments, offering a diversity of brands for Canadians across a national retail network.

Cautionary Statement:

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Forward-looking information          
This news release contains forward-looking information relating to the Company's proposed activities and other statements that are not historical facts. Forward-looking information relates to management's future outlook and anticipated events or results, and include statements or information regarding the future plans or prospects of the Company. Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. These factors include risks and uncertainties associated with or arising as a result of delays in obtaining or an inability to obtain required regulatory approvals, access to sufficient quantities of cannabis, the results of diligence investigations, the actions of third parties, the results of negotiations with third parties, developments in the cannabis sector, the ability to access sufficient capital from internal and external sources, reliance on key personnel, regulatory risks and delays and other risks and uncertainties discussed in the management discussion and analysis section of the Company's interim and most recent annual financial statement or other reports and filings, including those made with the CSE and applicable Canadian securities regulators. There can be no assurance that such forward looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward looking information.

SOURCE Choom Holdings Inc.


These press releases may also interest you

at 02:10
Ultimovacs ASA ("Ultimovacs", ticker ULTIMO), today announced that Ton Berkien will join Ultimovacs' management team as Chief Business Officer (CBO), effective December 1, 2020. Mr. Berkien will join Ultimovacs from his current position at Amgen as...

at 02:00
OMRON Healthcare Co., Ltd. announced on November 24 additional investment into AliveCor by its parent company, OMRON Corporation, as part of $65 million series E funding for the leader in AI-based personal electrocardiogram (ECG) technology. OMRON...

at 02:00
Evox Therapeutics Ltd ('Evox' or the 'Company'), a leading exosome therapeutics company, is pleased to announce that the Company has been granted another key patent by the European Patent Office (EPO). This new grant reinforces the Company's leading...

at 01:25
Mydecine Innovations Group Inc. (the "Company") announces that its previously issued financial statements for the fiscal year ended December 31, 2019, and the three- and six-month periods ended March 31, 2020 and June 30, 2020, any corresponding...

at 01:15
Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing oncolytic viruses to target hard-to-treat solid tumors, today releases 18-month follow-up data from the randomized phase I/II trial of ONCOS-102 in combination with...

at 00:30
The food recall warning issued on November 3, 2020 has been updated to include additional distribution information. This additional information was identified during the Canadian Food Inspection Agency's (CFIA) food safety investigation. Miss...



News published on 3 march 2020 at 06:00 and distributed by: